Visperterminen, Switzerland

Klaus Heinzmann

This inventor holds 10 USPTO granted patents. Top assignees: Lonza Inc., Lonza Ag, Lonzo Ltd.. Active years: 1992-2002.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 1992-2002

Loading Chart...
10 patents (USPTO):Explore Patents

Title: Klaus Heinzmann: Innovator in Biotechnological Processes

Introduction

Klaus Heinzmann is a prominent inventor based in Visperterminen, Switzerland. He has made significant contributions to the field of biotechnology, holding a total of 10 patents. His work focuses on innovative processes that enhance the production of various biotechnological compounds.

Latest Patents

Heinzmann's latest patents include a biotechnological process for preparing N-acetylmannosamine. He has also developed a biotechnical production process for piperazine R-α-carboxylic acids and piperazine S-α-carboxylic acid amide. Additionally, he has created a biologically pure culture of microorganisms capable of converting RS-α-piperazinecarboxamides into the corresponding R-α-piperazinecarboxylic acid, utilizing R-α-piperazinecarboxamides as the only nitrogen source.

Career Highlights

Throughout his career, Klaus Heinzmann has worked with notable companies such as Lonza Inc. and Lonza AG. His expertise in biotechnological processes has positioned him as a key figure in the industry, contributing to advancements that have practical applications in various fields.

Collaborations

Heinzmann has collaborated with several professionals in his field, including Andreas Kiener and Rainer Glockler. These partnerships have fostered innovation and have been instrumental in the development of his patented processes.

Conclusion

Klaus Heinzmann's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the industry positively, showcasing the importance of innovation in scientific research.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…